These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20047044)

  • 21. Are we ready for pandemic influenza H5N1?
    Stephenson I
    Expert Rev Vaccines; 2005 Apr; 4(2):151-5. PubMed ID: 15889987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic.
    Sambhara S; Poland GA
    Annu Rev Med; 2010; 61():187-98. PubMed ID: 20059335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adapting global influenza management strategies to address emerging viruses.
    Noah DL; Noah JW
    Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(2):L108-17. PubMed ID: 23709619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ins and outs of universal childhood influenza vaccination.
    Fraaij PL; Bodewes R; Osterhaus AD; Rimmelzwaan GF
    Future Microbiol; 2011 Oct; 6(10):1171-84. PubMed ID: 22004036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Achieving clinical equality in an influenza pandemic: patent realities.
    Kane EM
    Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public health strategies for distribution of influenza vaccine during an influenza pandemic.
    Hadler JL
    Yale J Biol Med; 2005 Oct; 78(5):277-86. PubMed ID: 17132334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
    Choo AY; Broderick KE; Kim JJ; Sardesai NY
    IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.
    Vajo Z; Tamas F; Sinka L; Jankovics I
    Lancet; 2010 Jan; 375(9708):49-55. PubMed ID: 20018367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS
    Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of seasonal and pandemic influenza: prospects for control.
    Monto AS
    Clin Infect Dis; 2009 Jan; 48 Suppl 1():S20-5. PubMed ID: 19067611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperation between government and industry in combating a perceived emerging pandemic. The 1976 swine influenza vaccination program.
    Hilleman MR
    JAMA; 1996 Jan; 275(3):241-3. PubMed ID: 8604179
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.
    Sym D; Patel PN; El-Chaar GM
    Ann Pharmacother; 2009 Dec; 43(12):2001-11. PubMed ID: 19920156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conceptional considerations for a German influenza pandemic preparedness plan.
    Fock R; Bergmann H; Bussmann H; Fell G; Finke EJ; Koch U; Niedrig M; Peters M; Scholz D; Wirtz A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):191-5. PubMed ID: 12458359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW.
    Fizzell J; Campbell-Lloyd S; Hallett AJ; Lowbridge CP; Meijer D; Tyner SE
    N S W Public Health Bull; 2010; 21(1-2):32-5. PubMed ID: 20374692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MF59-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations.
    Puig Barberà J; González Vidal D
    Expert Rev Vaccines; 2007 Oct; 6(5):659-65. PubMed ID: 17931147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of the Western Sydney and Nepean Blue Mountains local health districts' influenza prevention programme.
    Brown M; Sheppeard V; Gabriel S; Thomas J
    Intern Med J; 2013 Jul; 43(7):760-6. PubMed ID: 23656638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.